The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yu.V. Strunina

Association of Specialists in Health Technology Assessment

N.A. Petunina

Sechenov First Moscow State Medical University

Cost-effectiveness and budget impact analysis of fixed combination of alogliptin and pioglitazone in the treatment of type 2 diabetes mellitus

Authors:

Yu.V. Strunina, N.A. Petunina

More about the authors

Views: 801

Downloaded: 0


To cite this article:

Strunina YuV, Petunina NA. Cost-effectiveness and budget impact analysis of fixed combination of alogliptin and pioglitazone in the treatment of type 2 diabetes mellitus. Medical Technologies. Assessment and Choice. 2023;(3):70‑81. (In Russ.)
https://doi.org/10.17116/medtech20234503170

Recommended articles:
Psychopathological syndromes with sleep diso­rders in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(6):30-35
Risk factors for severe pre-eclampsia in pregnant women with type 2 diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2023;(5):61-65
Type 2 diabetes mellitus and COVID-19: lethality predictors. Russian Journal of Preventive Medi­cine. 2023;(11):53-56

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.